Lyme Disease Antibody Screen (Blood Test) Biomarker Testing
It screens your blood for antibodies to Lyme bacteria to support next-step testing and care, with convenient ordering and Quest draw access via Vitals Vault.
With Vitals Vault, you have access to a comprehensive range of biomarker tests.
A Lyme Disease Antibody Screen is a blood test that looks for your immune system’s response to the bacteria that cause Lyme disease (Borrelia burgdorferi). It is usually used as a first-step “screening” test when you have symptoms or exposure risk that make Lyme a reasonable possibility.
Because it measures antibodies (your body’s defense proteins), timing matters. If you test too early, your immune system may not have made enough antibodies yet, and the result can look negative even if infection is present.
This test is most helpful when it is interpreted alongside your symptoms, your tick exposure history, and follow-up testing when indicated. It supports clinician-directed care and is not, by itself, a standalone diagnosis.
Do I need a Lyme Disease Antibody Screen test?
You may consider a Lyme Disease Antibody Screen if you have had possible tick exposure and you developed symptoms that fit Lyme disease, such as a new expanding rash, fever or chills, headache, neck stiffness, new joint pain or swelling (often a knee), facial weakness, or unexplained fatigue that started after time outdoors in an area where ticks are common.
Testing can also make sense when symptoms are less specific but persistent, and other common causes have not explained what is going on. In those cases, the goal is not to “prove” Lyme from one number, but to decide whether Lyme belongs on the short list and whether confirmatory testing is warranted.
You may not need this test if you have a classic bull’s-eye–type rash (erythema migrans) and a clinician is ready to treat based on the clinical picture, because early antibody tests can be negative. On the other hand, if you are testing for reassurance after a tick bite but you feel well, your clinician may recommend watchful waiting or testing at a specific time window rather than testing immediately.
If you are pregnant, immunocompromised, or you have neurologic symptoms (like facial droop, severe headache, or numbness), it is especially important to use testing as part of a clinician-guided plan, because the right next step may be different than for uncomplicated cases.
This is a CLIA-certified laboratory blood test; results should be interpreted with your symptoms and, when appropriate, confirmatory testing rather than used as a standalone diagnosis.
Lab testing
Order a Lyme Disease Antibody Screen through Vitals Vault
Schedule online, results typically within about a week
Clear reporting and optional clinician context
HSA/FSA eligible where applicable
Get this test with Vitals Vault
If you are trying to make sense of possible Lyme symptoms or you are reviewing a prior result, Vitals Vault lets you order a Lyme Disease Antibody Screen and complete your blood draw through the Quest network.
Once your result is back, you can use PocketMD to walk through what a negative, equivocal, or positive screen typically means, what follow-up testing is commonly recommended (such as an immunoblot), and how timing since exposure can change interpretation.
If your situation calls for broader context, you can also map your next steps with related labs (for example, inflammation markers or other infectious workups) and decide with your clinician whether repeat testing is appropriate.
- Order online and schedule a local Quest draw
- PocketMD helps you interpret results and plan follow-ups
- Easy re-testing when timing is the key variable
Key benefits of Lyme Disease Antibody Screen testing
- Helps determine whether your immune system has mounted a response consistent with Lyme exposure.
- Supports the recommended two-step approach by identifying when confirmatory testing is needed.
- Adds context when symptoms are compatible with Lyme but not specific enough to diagnose clinically.
- Can help distinguish “unlikely Lyme” from “needs a closer look,” especially in moderate-risk scenarios.
- Provides a baseline result that can be compared with a repeat test when early infection is still possible.
- Helps avoid over-interpreting nonspecific symptoms by anchoring decisions to objective lab evidence.
- Pairs well with PocketMD guidance so you can understand timing, false negatives, and next steps.
What is a Lyme Disease Antibody Screen?
A Lyme Disease Antibody Screen is a serology test, meaning it looks for antibodies in your blood rather than looking directly for the bacteria. Most screening tests use an enzyme immunoassay (EIA) or immunofluorescence assay (IFA) to detect antibodies that react to Borrelia burgdorferi.
A key point is that antibodies take time to develop. In the first days to couple of weeks after infection, you may have symptoms but still test negative because your immune response has not fully ramped up.
Many labs report the screen as negative, equivocal (borderline), or positive. When the screen is positive or equivocal, the usual next step is a confirmatory test (often called an immunoblot) that looks for a more specific antibody pattern. This two-step strategy is designed to reduce false positives while still catching true infections.
What the test does (and does not) tell you
A positive screen suggests your immune system has antibodies that react to Lyme-related antigens, but it does not prove active infection on its own. Antibodies can persist after prior infection and treatment, and cross-reactions can occur with other conditions. A negative screen lowers the likelihood of Lyme, but it does not fully rule it out if testing was done too early or if your clinical picture strongly suggests Lyme.
Why timing since exposure matters
If your symptoms started very recently, your clinician may recommend repeating serology after a short interval if suspicion remains. In early localized Lyme, a rash can appear before antibodies are detectable. Later in the illness, antibody tests are more likely to be positive, but interpretation can be complicated by past infection or treatment history.
What do my Lyme Disease Antibody Screen results mean?
Negative (no antibodies detected on the screen)
A negative Lyme antibody screen means the test did not detect a measurable antibody response at the time your blood was drawn. This makes Lyme disease less likely, especially if your symptoms began weeks ago. However, if you tested very early (often within the first 1–2 weeks after infection), antibodies may not be detectable yet, and a repeat test may be considered if symptoms and exposure risk remain convincing. A negative result also does not explain symptoms that come from other infections, autoimmune conditions, or non-infectious causes.
Equivocal or borderline (indeterminate screen)
An equivocal result means the antibody signal is near the lab’s cutoff, so the screen cannot clearly be called negative or positive. This can happen early in infection, during a nonspecific immune response, or because of technical variation around the threshold. In many settings, the next step is confirmatory testing (immunoblot) and/or repeating the test after an appropriate interval based on when symptoms started. Your clinician will weigh this result against your exposure history and the type and timing of symptoms.
Positive (antibodies detected on the screen)
A positive screen indicates antibodies that react to Lyme-related targets were detected. On its own, this does not confirm active Lyme disease, because antibodies can remain after a past infection and false positives can occur from cross-reactivity. Most of the time, a positive screen should be followed by a confirmatory immunoblot to improve specificity and clarify whether the pattern fits Lyme. If you have symptoms consistent with Lyme, a positive screen increases the likelihood that Lyme is part of the explanation, but treatment decisions should be made with a clinician.
Factors that influence Lyme antibody results
The biggest factor is timing: testing too soon after infection can produce a false negative. Prior Lyme infection and prior treatment can leave antibodies detectable for months or years, which can complicate interpretation if new symptoms arise. Other infections or immune conditions can sometimes cause cross-reactive antibodies and a false-positive screen. Immune suppression (certain medications or conditions) can blunt antibody production and reduce test sensitivity.
What’s included
Frequently Asked Questions
How soon after a tick bite will a Lyme antibody test be positive?
Antibodies often take time to become detectable. In the first 1–2 weeks after infection, a Lyme antibody screen can be negative even if you have symptoms. If suspicion remains, clinicians commonly consider repeat serology after additional time has passed or use other evaluations based on your presentation.
Do I need to fast for a Lyme Disease Antibody Screen?
Fasting is not typically required for Lyme antibody screening. You can usually eat and drink normally unless your clinician or your lab order includes other tests that do require fasting.
What is the difference between a Lyme antibody screen and a Western blot?
The antibody screen is a first-step test designed to be sensitive, often using an EIA method. A Western blot or immunoblot is usually a confirmatory test that looks for a more specific antibody pattern. Many testing algorithms use the screen first, then an immunoblot if the screen is positive or equivocal.
Can you have Lyme disease with a negative antibody screen?
Yes, especially early on. If you test before your immune system has produced detectable antibodies, the screen may be negative. A clinician will consider your timing, symptoms, and exposure risk to decide whether repeat testing or other evaluation is appropriate.
Does a positive Lyme antibody screen mean I have active Lyme disease right now?
Not necessarily. A positive screen means antibodies were detected, but antibodies can persist after a past infection and treatment. Confirmatory testing and clinical context help determine whether the result fits an active infection versus prior exposure or a false positive.
Should I retest if my result is equivocal?
Equivocal results often lead to confirmatory testing and sometimes repeat testing, depending on how long you have had symptoms and how likely Lyme is based on exposure. Your clinician may recommend an immunoblot, repeating serology after a defined interval, or pursuing other diagnoses if the overall picture does not fit Lyme.
What other tests are commonly ordered with Lyme testing?
Follow-up often includes confirmatory Lyme immunoblot testing when the screen is positive or equivocal. Depending on symptoms, clinicians may also check markers of inflammation, evaluate other tick-borne infections, or order neurologic or joint-focused testing. The right combination depends on your specific symptoms and timing.